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We read the article “Comparison of inflammation, arter-
ial stiffness and traditional cardiovascular risk factors be-
tween rheumatoid arthritis and inflammatory bowel
disease” by Fan et al. [1] with great interest. In this very-
well designed study, authors found that pulse wave vel-
ocity (PWV) levels were similar between rheumatoid
arthritis (RA), inflammatory bowel disease (IBD) and
control groups. In addition, they also showed that ankle
brachial ındex (ABI) levels were higher in controls than
IBD, but not RA. They concluded that traditional risk
factors, but not inflammatory markers, are major param-
eters asscociated with arterial stiffness. These findings
provide new information about the asscociation between
inflammatory diseases and atherosclerosis.
In this study, although RA patients have higher Fra-
mingham risk score and number of hypertensive pa-
tients, there was no significant difference between RA
and control groups in PWV and ABI levels. Arterial stiff-
ness has been known as an independent predictor car-
diovascular mortality and is increased in rheumathologic
diseases despite a low risk for cardiovascular disease ac-
cording to Framingham score [2]. Moreover, in IBD pa-
tients, ABI levels were significantly decreased when
compared to control subjects, but PWV levels were not
correlated with ABI. Whereas a negative correlation be-
tween PWV and ABI was demonstrated in individuals
without organic heart disease [3].
We suggest some possible explanations for the lack of
increased PWV and decreased ABI in patients with RA
and IBD than controls. In present study, authors did not
examine renal function tests and hemoglobin levels. We
know that patients with chronic renal failure and anemia
have increased risk for cardiovascular events and periph-
eral artery disease [4, 5]. Moreover, they did not examine
the association of disease extent and duration with vas-
cular parameters. We think that as disease extent and
duration increased, risk of atherosclerosis will be in-
creased due to long-term exposure to inflammation.
Before making certain comments on these findings, we
think that this study should be reconsidered in light of
the above mentioned suggestions. This could provide
the readers of the journal clearer information regarding
the effects of inflammatory diseases in atherosclerosis.
Authors’ Response:
Dear Editors of Journal of Inflammation,
We are writing in response to the letter concerning
our manuscript. We appreciate the interest in our work.
As noted, we did not observe a significant increase in
mean baPWV in RA patients [1]. Whilst RA has been
associated with an increased prevalence of arterial stiff-
ness. there are other other studies that also failed to find
an increase in PWV [6, 7] in these patients. Another
study reported that only about 30 % of RA patients had
increased arterial stiffness [8]. In IBD, PWV has been
found to be increased [9] or unchanged [10]. Thus, find-
ings on arterial stiffness in RA and IBD patients have
varied between studies, possibly due to the difference in
demographics of patients studied.
In our study, most patients were well controlled by
treatment with disease modifiying drugs. It is known
that disease modifying drugs improve endothelial dys-
function and reduce arterial stiffness [11–13]. Disease
duration and activity are also likely to influence arterial
stiffness [8, 14]. We thus examined the correlations be-
tween disease duration and vascular parameters. We did
not examine correlations with disease activity since most
patients were in remission. PWV was correlated with
disease duration in patients with IBD (r = 0.343, p =
0.026) but not with RA. Other investigators also did not
find correlations between PWV and disease duration or
activity [15]. This study also reported that among the
many factors related to arterial stiffness, only old age
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and high systolic blood pressure were major determi-
nants, which is concistent with our findings. ABI was
not corrrelated with vascular parameters in either RA or
IBD. Although negative correlation between PWV and
ABI have been demonstrated in individuals without or-
ganic heart disease [3], we did not observe such inverse
correlation in our study.
Finally, we appreciate and agree with the comment
that patients with chronic renal failure and anaemia have
increased risk for cardiovascular events and peripheral
artery disease [4, 5]. As suggested we have examined
data on renal function (urea, creatinine) and haemoglo-
bin, which are all within the normal range (Table 1).
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Table 1 Laboratory results of study population
RA (n = 43) IBD (n = 42)
Urea, mg/dL 5.6 ± 2.2 5.8 ± 2.5
Creatinine, μmoL/L 68.7 ± 16.2 79.9 ± 38.1
Hemoglobin, g/L 134.1 ± 18.4 137.4 ± 16.5
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